31 – 40 of 52
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies
(
- Contribution to journal › Article
- 2001
-
Mark
Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level
(
- Contribution to journal › Article
-
Mark
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml
(
- Contribution to journal › Article
-
Mark
The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease
(
- Contribution to journal › Article
-
Mark
Complexes between activated protein C and protein C inhibitor measured with a new method: comparison of performance with other markers of hypercoagulability in the diagnosis of deep vein thrombosis
(
- Contribution to journal › Article
- 2000
-
Mark
Studies on phenotypic expression patterns of proteases and protease inhibitors in benign compared to malignant prostate tissues
(
- Contribution to journal › Article
-
Mark
Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden
(
- Contribution to journal › Article
-
Mark
Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater
(
- Contribution to journal › Article
-
Mark
Sensitive and specific immunodetection of human glandular kallikrein 2 in serum
(
- Contribution to journal › Article
-
Mark
Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer
(
- Contribution to journal › Article